Logo image of PMCB

PHARMACYTE BIOTECH INC (PMCB) Stock Analyst Ratings

NASDAQ:PMCB - Nasdaq - US71715X2036 - Common Stock - Currency: USD

0.885  +0.04 (+4.12%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to PMCB. The Buy consensus is the weighted average rating of the current analysts ratings.

PMCB was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about PMCB.
In the previous month the buy percentage consensus was at a similar level.
PMCB was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

PMCB Historical Analyst RatingsPMCB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5

Related screens

PMCB Current Analyst RatingPMCB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2021-11-08 HC Wainwright & Co. Initiate Neutral